States should be able to design their own models for methadone access to eliminate federal barriers to using it for opioid use disorder (OUD) treatment, according to the American Society of Addiction Medicine (ASAM). In its most recent lobbying efforts, the group proposed four models to replace federally defined structures with state-defined ones. Even though […]
All fentanyl-related substances could soon be classified as Schedule I substances by the Attorney General and the Drug Enforcement Administration. The bipartisan but Republican-led Halt All Lethal Trafficking of Fentanyl Act, also called the “HALT” Fentanyl Act, cleared the House and Senate as of June 12 and will soon hit President Trump’s desk to be […]
Opioid use disorder (OUD) costs the U.S. around $94.3 billion annually. To put that in perspective, that’s the same amount the President of the Philippines asked for to support its entire government budget in 2023. The price tag per person among the 6.1 million people who have an OUD lands somewhere around $700,000 per case. […]
The Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) have delayed the finalization of a rule meant to lock in addiction treatment-related telehealth flexibilities first implemented during the COVID-19 pandemic. On March 20, the agencies released the text of a final rule that pushed back the effective date of […]
The Drug Enforcement Administration (DEA) will extend its telehealth flexibilities past the end of the year. Health care providers that have linked telehealth and controlled substance prescribing have been staring down a regulatory cliff following inaction by Congress on the issue. Twice already, the DEA has extended COVID-era regulation that provided wide flexibility when it […]
The Drug Enforcement Administration (DEA) appears to be leaning toward releasing a rule that would put strict limits on telehealth prescribing. However, telehealth advocates maintain that the strictness of the yet-to-be-released rule effectively makes prescribing controlled substances via telehealth impossible. If finalized, the rule that the DEA is considering would severely limit the ability of […]
The arrests of Done Global executives could not have come at a worse time for the industry. Granted, there is never a good time for such an event. It just so happens that, right now, the arrests of executives of the heavily scrutinized digital ADHD treatment provider could play heavily in how several unresolved industry […]
The Drug Enforcement Administration is preparing to release its final rule for telehealth and controlled substances. On Thursday, the White House’s Office of Management and Budget (OMB) received the final rule from the DEA. The OMB oversees the coordination and review of major executive branch actions. It’s the final stop before the final rules are […]
The federal government will extend COVID-era telehealth flexibilities until December 2024, dramatically extending the runway for the Drug Enforcement Administration (DEA) to establish new rules for using telehealth and controlled substances. The DEA and U.S. Department of Health and Human Services released a new temporary rule on Oct. 6 after conducting two days of listening […]
Key Drug Enforcement Administration (DEA) leaders said little last week during the roughly 11 hours of live presentations heard over two days of listening sessions regarding the future of telehealth and prescribing controlled substances. What they did say, however, helps clarify what is top of mind for the DEA as the agency considers re-approaching how […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
